What Are the Key Statistics About Gestational Trophoblastic Disease?
Gestational trophoblastic disease (GTD) occurs in about 1 pregnancy out of 1,000 in the United States. Most of these are hydatidiform moles.
Choriocarcinoma , a malignant form of gestational trophoblastic disease (GTD), is even less common, affecting around 2 to 7 of every 100,000 pregnancies in the United States.
Choriocarcinoma and other forms of GTD are more common in many Asian and African countries.
Overall, gestational trophoblastic tumors account for less than 1% of female reproductive system cancers.
Cure rates depend on the type of GTD and its stage, as described in Treatment of Gestational Trophoblastic Disease, by Type and Stage.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
Last Medical Review: November 10, 2017 Last Revised: November 27, 2017
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.